Last update 24 May 2025

P30-EPS vaccine(Duke University)

Overview

Basic Info

Drug Type
Synthetic peptide vaccine, Therapeutic vaccine
Synonyms
P30-linked EphA2, CMV pp65, and survivin vaccination(Duke University), P30 EPS, P30-EPS
+ [1]
Target
CMV pp65 x EphA2 x survivin
Action
modulators, antagonists, inhibitors,
+ [1]
Mechanism
CMV pp65 modulators(Cytomegalovirus pp65 Antigen modulators), EphA2 antagonists(Ephrin type-A receptor 2 antagonists), survivin inhibitors(Baculoviral IAP repeat-containing protein 5 inhibitors)
Therapeutic Areas
NeoplasmsNervous System DiseasesOther Diseases
Active Indication
Glioblastoma Multiforme
Inactive Indication-
Originator Organization
Duke UniversityDuke University
Active Organization
Duke UniversityDuke University
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with P30-EPS vaccine(Duke University)
NCT05283109
/ Active, not recruitingPhase 1IIT
ETAPA I: Evaluation of Tumor Associated P30-Peptide Antigen I; A Pilot Trial of Peptide-based Tumor Associated Antigen Vaccines in Newly Diagnosed, Unmethylated, and Untreated Glioblastoma (GBM)
100 Clinical Results associated with P30-EPS vaccine(Duke University)
Login to view more data
100 Translational Medicine associated with P30-EPS vaccine(Duke University)
Login to view more data
100 Patents (Medical) associated with P30-EPS vaccine(Duke University)
Login to view more data
100 Deals associated with P30-EPS vaccine(Duke University)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Glioblastoma MultiformePhase 1
United States
Duke UniversityDuke University
30 Aug 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free